IL7 and cancer: Recombinant human IL-7 has been reported to increase CD4+ and CD8+ T cells in the periphery of cancer patients [59], while the expression of IL-12 in melanoma patients also increases the infiltration of CD8+ cytotoxic T cells into tumors [33].